F S&P 500
5,355.75 +27.75 (+0.52%) F Dow Jones
39,819.00 +36.00 (+0.09%) F Nasdaq
18,939.50 +152.75 (+0.81%) E-mini Russell 2000 Index Futur
2,094.50 +5.40 (+0.26%) Petróleo
77.07 -0.50 (-0.64%) Oro
2,371.50 -21.40 (-0.89%)
Dishman Carbogen Amcis Limited (DCAL.NS)
Dishman Carbogen Amcis Limited
Dishman Corporate House
Iscon–Bopal Road Ambli
Ahmedabad 380058
India
91 27 1742 0102
https://imdcal.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 1,295
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Arpit Janmejay Vyas | Global MD & Director | N/D | N/D | 1986 |
| Ms. Deohooti Janmejay Vyas | Whole Time Director | 12M | N/D | 1951 |
| Mr. Harshil R. Dalal | Global Chief Financial Officer | N/D | N/D | N/D |
| Mr. Paolo Armanino | Chief Operating Officer of Indian Operations | N/D | N/D | N/D |
| Ms. Shrima Gaurangbhai Dave | Compliance Officer & Company Secretary | N/D | N/D | N/D |
| Mr. Dharmesh Desai | GM of Secretarial & Legal | N/D | N/D | N/D |
| Mr. . HUZIFA | Sales Manager | N/D | N/D | N/D |
| Dieter Thuer | Global Head of HR | N/D | N/D | N/D |
| Mr. Pascal Villemagne | Chief Executive Officer of CARBOGEN AMCIS | N/D | N/D | N/D |
| Dr. Himani S. Dhotre | CEO of Projects & Operations | N/D | N/D | N/D |
Descripción
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitizers, antiseptics, vitamin D analogues, cholesterol, lanolin-related products, disinfectant formulations, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited operates as a subsidiary of Adimans Technologies LLP.
Gestión corporativa
La calificación ISS Governance QuickScore de Dishman Carbogen Amcis Limited a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
